Proven interventions to improve care, address disparities, and support lipid management are woven throughout AMGA Foundation's new framework to guide population health–based secondary prevention strategies for atherosclerotic cardiovascular disease (ASCVD).
Alexandria, Virginia — “Population Health Approach to Secondary Prevention for ASCVD Framework and Infographic" is a new offering from the AMGA Foundation, whose goal is to improve health care within the US through population health and quality initiatives.
Through its ASCVD Best Practices Learning Collaborative, the AMGA Foundation worked with 12 health care organizations to address the management and treatment of atherosclerotic cardiovascular disease (ASCVD), identifying both successes and challenges to best inform strategies targeted at improving patient care and outcomes. The main goals of the report are to provide a practical, evidence-based framework for improving the secondary prevention and management of ASCVD and to support health care organizations in implementing proven interventions that enhance clinical decision-making, promote team-based care, address health disparities, and improve lipid management and patient adherence.
In ASCVD, plaques attach and build up in arterial walls, and have potential to cause damaging, if not deadly, heart attacks, stroke, and aortic atherosclerotic disease.
John W. Kennedy, MD | Image Credit: © AMGA Foundation
"ASCVD is a major contributor to cardiovascular disease, the leading cause of death in the United States. Collaborative participating groups made great progress in implementing interventions identified for successful patient care in secondary prevention of ASCVD,” said John Kennedy, MD, AMGA Foundation president and AMGA chief medical officer, in a press release announcing the report. “Using these learnings and applying a population health approach, we can contribute to improved care for millions of patients living with ASCVD.”
Click to learn more about the report and the AMGA Foundation.
Many Patients Stop GLP-1s Before Reaching Target Dose: Hamlet Gasoyan, PhD
June 19th 2025Discontinuing the weight loss treatment before hitting the recommended maintenance dose contributes to low-value care despite provider follow-up and efforts to manage side effects, says Hamlet Gasoyan, PhD, Cleveland Clinic.
Read More
Mental Health Awareness: Transforming Workplace Support and Engagement
May 20th 2025Explore how employers enhance workplace mental health by fostering a culture of support and engagement, focusing on holistic well-being strategies in this interview with Jim Kinville, MA, University of Pittsburgh Medical Center.
Listen